Ceragon reported Q4 2025 revenues of $82.3 million, GAAP operating income of $2.4 million, and GAAP net income of $0.1 million. For the full year 2025, revenues were $338.7 million, GAAP operating income was $7.2 million, and GAAP net loss was $(2.1) million. The company ended 2025 with a strengthened balance sheet, including $38.4 million in cash and cash equivalents.
Q4 2025 revenues were $82.3 million, consistent with the January update.
GAAP operating income for Q4 2025 was $2.4 million, with non-GAAP operating income at $3.4 million.
Ceragon ended 2025 with $38.4 million in cash and cash equivalents, an increase from $35.3 million at the end of 2024.
North American momentum continued, with backlog entering 2026 nearly double that of entering 2025.
For 2026, Ceragon expects revenue between $355 million and $385 million, with a non-GAAP operating margin of 6.5% to 7.5% at the midpoint of the revenue range, reflecting currency assumptions established in January.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance